enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Galena Biopharma - Wikipedia

    en.wikipedia.org/wiki/Galena_Biopharma

    Galena Biopharma, Inc. (originally RXi Pharmaceuticals) was a publicly traded pharmaceutical company based in San Ramon, California. The company was founded in Worcester , Massachusetts . In 2011, it moved to Oregon, [ 1 ] [ 2 ] and in 2015 moved to San Ramon, California . [ 3 ]

  3. List of largest biomedical companies by revenue - Wikipedia

    en.wikipedia.org/wiki/List_of_largest_biomedical...

    The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.

  4. Is Regeneron Pharmaceuticals Due for a Stock Split? - AOL

    www.aol.com/regeneron-pharmaceuticals-due-stock...

    Regeneron Pharmaceuticals (NASDAQ: REGN) stock is trading above the $1,000 mark. It's at a high enough threshold that the company could decide to split its stock. That would lower the share price ...

  5. Revvity - Wikipedia

    en.wikipedia.org/wiki/Revvity

    Revvity, Inc. is an American company in the life sciences and diagnostics business that is focused on selling to the pharmaceutical and biotechnology industries, [1] especially in relation to approaches making use of new cell therapy or gene therapy developments. [2]

  6. Horizon Therapeutics - Wikipedia

    en.wikipedia.org/wiki/Horizon_Therapeutics

    On May 2, 2019, shareholders of the company approved the change of the company's name from Horizon Pharma plc to Horizon Therapeutics plc. [ 13 ] In January 2020 – after showing very strong PhIII data – it was approved for the treatment of thyroid eye disease (TED), a rare vision-threatening disease that previously had no FDA-approved ...

  7. Why Is Vertex Pharmaceuticals Stock Trading Lower On Thursday ...

    www.aol.com/finance/why-vertex-pharmaceuticals...

    On Thursday, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) announced results from its Phase 2 study of suzetrigine for painful lumbosacral radiculopathy (LSR), a disorder that causes pain in ...

  8. Better Biotech Stock: Viking Therapeutics vs. Madrigal ... - AOL

    www.aol.com/finance/better-biotech-stock-viking...

    For premium support please call: 800-290-4726 more ways to reach us

  9. Azenta - Wikipedia

    en.wikipedia.org/wiki/Azenta

    The latter will focus exclusively on their life science division. [12] In August 2022, Azenta Life Sciences has come to a definitive agreement to acquire B Medical Systems S.á.r.l., in a transaction of approx. €410 million (with an additional €50 million in future performance milestones) is expected to be completed by October 2022. [13]